Literature DB >> 28694399

Familial hypertrophic cardiomyopathy: A case with a new mutation in the MYBPC3 gene.

Olgu Hallıoğlu Kılınç, Dilek Giray1, Atıl Bişgin, Sevcan Tuğ Bozdoğan, Derya Karpuz.   

Abstract

Familial hypertrophic cardiomyopathy is a genetically heterogeneous disease with variable clinical features that is inherited as autosomal dominant with variable penetrance. Recent developments in genetics of hereditary cardiomyopathy have not only enlightened many points about pathogenesis, but have also provided great benefit to diagnostic approaches of clinicians. Heterozygous mutation of c3691-3692insTTCA in MYBPC3 gene was identified in a pediatric patient with diagnosis of hypertrophic cardiomyopathy at clinic. Hypertrophy was observed in sister and father of the patient in echocardiography screening, and it was subsequently determined that they also had same mutation. This mutation has not previously been defined and reported previously in the literature as cause of hypertrophic cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28694399     DOI: 10.5543/tkda.2016.56267

Source DB:  PubMed          Journal:  Turk Kardiyol Dern Ars        ISSN: 1016-5169


  1 in total

1.  Genetic determinants of clinical phenotype in hypertrophic cardiomyopathy.

Authors:  Lazar Velicki; Djordje G Jakovljevic; Andrej Preveden; Miodrag Golubovic; Marija Bjelobrk; Aleksandra Ilic; Snezana Stojsic; Fausto Barlocco; Maria Tafelmeier; Nduka Okwose; Milorad Tesic; Paul Brennan; Dejana Popovic; Arsen Ristic; Guy A MacGowan; Nenad Filipovic; Lars S Maier; Iacopo Olivotto
Journal:  BMC Cardiovasc Disord       Date:  2020-12-09       Impact factor: 2.298

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.